Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Summary

This reports provides a data-driven overview of the current and future competitive landscape in mpox therapeutics.

In the 10 pharmaceutical markets covered in GlobalData’s epidemiology fact sheet, GlobalData epidemiologists estimated a total of 66,674 incident cases of mpox in 2022.

Tecovirimat (Tpoxx) is the only approved medication for the treatment of severe complications of mpox that is available in both an oral and intravenous formulation.

The R&D activity in mpox is poor, with only two molecules in Phase III development.

Non-commercial sponsors dominate clinical trial development in mpox, with the US emerging as the key country for conducting Phase III trials in mpox.

Globally, partnerships were the most common type of deals involving companies developing mpox assets.

Scope

GlobalData’s mpox: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the report include -

Disease Landscape

Disease Overview

Epidemiology Overview

Treatment Overview

Marketed Products Assessment

Breakdown by Mechanism of Action, Molecule Type, Route of Administration

Product Profiles with Sales Forecast

Pricing and Reimbursement Assessment

Annual Therapy Cost

Time to Pricing and Time to Reimbursement

Pipeline Assessment

Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration

Product Profiles with Sales Forecast

Late-to-mid-stage Pipeline Drugs

Phase Transition Success Rate and Likelihood of Approval

Clinical Trials Assessment

Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status

Enrolment Analytics, Site Analytics, Feasibility Analysis

Deals Landscape

Mergers, Acquisitions, and Strategic Alliances by Region

Overview of Recent Deals

Commercial Assessment

Key Market Players

Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the mpox market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global mpox market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.